GENENTECH 4Q PROFITS UP, BUT NOT PER-SHAREGenentech Inc. (NYSE:GNE) of South San Francisco, Calif., saidthat an increase in the number of outstanding shares, resultingfrom last year's merger with Roche Holdings Ltd., caused per-share profits to decline.

The company said that a previously reported $167.7 millionspecial charge, also merger-related, caused its loss for the year.At the end of 1990, the company said it had $691.3 million incash, compared with $205 million at the end of 1989.

Fourth quarter ended Dec. 31(Figures in thousands except per-share data.)

1990 1989 Percent change

Revenues 131,250 111,418 +18Net income 17,143 15,520 +10Net income per share .15 .18 -17Outstanding shares 111,708 86,743 +29

Year ended Dec. 31(Figures in thousands except per-share data.)

1990 1989 Percent change

Revenues 476,136 400,455 +19Net income (loss) (98,031) 43,961 n.a.Net income per share (loss) (1.05) .51 n.a.Outstanding shares 93,040 85,967 +8

COLLABORATIVE RESEARCH POSTS LARGE LOSS

Collaborative Research Inc. (NASDAQ:CRIC) of Bedford, Mass.,reported that sales of biomedical products increased 6 percentfrom a year ago and contract and grant revenues rose 8percent. Sales of diagnostic products and services declined dueto a one-time sale of equipment in last year's first quarter. Thecompany said its total costs and expenses increased inproportion to the increase in revenues.

First quarter ended Dec. 1

(Figures in thousands except per-share data.)

1990 1989 Percent change

Revenues 2,167 2,090 +4Net income (loss) (884) (185) -378Net income per share (loss) (.08) (.02) -300Outstanding shares 10,658 10,656 negl.

BRISTOL-MYERS SQUIBB REPORTS 4Q PROFITS

Bristol-Myers Squibb Co. of New York said last year's fourth-quarter loss was due to an $855 million charge related to itsmerger of Bristol-Myers and Squibb.

Fourth quarter ended Dec. 31(Figures in thousands except per-share data.)

1990 1989 Percent change

Revenues 2,740,000 2,360,000 +16Net income (loss) 425,000 (353,000) n.a.Net income per share (loss) .81 (.67) n.a.

Year ended Dec. 31(Figures in thousands except per-share data.)

1990 1989 Percent change

Revenues 10,300,000 9,190,000 +12Net income 1,750,000 747,000 +134Net income per share 3.33 1.43 +133

IMMUCOR REPORTS BIG EARNINGS INCREASE

Immucor Inc. (NASDAQ:BLUD) of Norcross, Ga., said the increasein second-quarter revenues partly reflect the acquisition lastSeptember of Immuncor GmbH of Germany.

Second quarter ended Nov. 30

(Figures in thousands except per-share data.)

1990 1989 Percent change

Revenues 4,987 2,927 +70Net income 703 486 +45Net income per share .13 .10 +30Outstanding shares 5,328 5,089 +5

(c) 1997 American Health Consultants. All rights reserved.

No Comments